Hongzhou Lu
- Infectious Diseases top 5%
- Neurology top 10%
- Epidemiology
- Molecular Biology
- Oncology
- Topics
- HIV Research and Treatment (4 papers)COVID-19 Clinical Research Studies (3 papers)Long-Term Effects of COVID-19 (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Hongzhou Lu
11 papers receiving 414 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 265
- Neurology 112
- Epidemiology 62
- Molecular Biology 60
- Oncology 57
Countries citing papers authored by Hongzhou Lu
This map shows the geographic impact of Hongzhou Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Lu more than expected).
Fields of papers citing papers by Hongzhou Lu
This network shows the impact of papers produced by Hongzhou Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Lu. The network helps show where Hongzhou Lu may publish in the future.
Co-authorship network of co-authors of Hongzhou Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Hongzhou Lu. A scholar is included among the top collaborators of Hongzhou Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzhou Lu. Hongzhou Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 54 | |
| 6 | 299 | |
| 7 | 5 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases. | 11 |
| 11 | 26 |
About Hongzhou Lu
Hongzhou Lu is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 11 papers that have together received 423 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Infectious Diseases (265 citations), Neurology (112 citations) and Internal Medicine (27 citations). Hongzhou Lu has collaborated with scholars based in China and United States. Frequent co-authors include Taisheng Li, Wenhong Zhang, Shaoping Huang, Liping Chen, Xin Cheng, Jingmao Yang, Jilin Cheng, Jie An, Jinku Bao and Jingqiu Cheng. Their work appears in journals such as Frontiers in Immunology, International Journal of Infectious Diseases and Nutrition Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.